AG375

µ Opioid Receptor control peptide

• UNSPSC Code: 51111800
• NACRES: NA.41
• eCl@ss: 32160405

Eigenschaften

• conjugate: unconjugated
• concentration: 2 mg/mL
• technique(s): inhibition assay: suitable
• UniProt accession no.: P33535
• target post-translational modification: unmodified
• Quality Level: 100
• Gene Information: rat ... OPRM1(25601)

Beschreibung

Application

Antibody blocking studies (AB5511 and AB5509). Antibody should be pre-incubated with the peptide prior to incubation with the tissue/sample. It is suggested to pre-incubate for one hour at room temperature. A 10^-6 to 10^-5molar (M) peptide concentration is suggested to block antibody binding.

Optimal working dilutions must be determined by end user.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

Mu opioid receptor control peptide for use with the anti-Mu Opioid Receptor Antibodies AB5509 and AB5511. Synthetic peptide corresponding to the C-terminus of rat mu Opioid receptor comprising residues 384-398.

Physical form

Presented as a liquid.

Preparation Note

Store at -20°C in undiluted aliquots for up to 6 months after date of receipt. Avoid repeated freeze/thaw cycles.